T1	Participants 875 941	patients with coronary heart disease (CHD) or CHD risk equivalents
T2	Participants 977 1078	Eligible patients at National Cholesterol Education Program-Adult Treatment Panel III LDL-C treatment
T3	Participants 1727 1815	total of 2,757 patients were screened at 153 centers in 20 countries, and 1,623 patients
